EIF2AK4 and Miyoshi myopathy: Alternatively, GCN2 activation may be a downstream consequence of tumour-associated immune cell-induced amino acid shortages in the tumour microenvironment58,59, which if dissected could reveal combinatorial immune strategies for MM patients.